Reproducibility of single-sample clearance of 99mTc- mercaptoacetyltriglycine and 131I-orthoiodohippurate

Journal of Nuclear Medicine

Volumn 40, Issue 7, 1999, Pages 1122-1124

  Russell, Charles D ^a,b   Dubovsky, Eva V ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA HOSPITAL   (United States)

Author keywords

Kidney function; Mercaptoacetyltriglycine; Orthoiodohippurate; Precision; Renal clearance

Indexed keywords

IODOHIPPURATE SODIUM I 131; MERTIATIDE TC 99M;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG CLEARANCE; HUMAN; KIDNEY PLASMA FLOW; MAJOR CLINICAL STUDY; PARAPLEGIA; PRIORITY JOURNAL; QUADRIPLEGIA; REPRODUCIBILITY; RETROSPECTIVE STUDY; SPINAL CORD INJURY;

HUMANS; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; KIDNEY; RADIOPHARMACEUTICALS; RENAL PLASMA FLOW, EFFECTIVE; REPRODUCIBILITY OF RESULTS; SPINAL CORD INJURIES; TECHNETIUM TC 99M MERTIATIDE;

EID: 0032976191     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lloyd LK, Dubovsky EV, Bueschen AJ, et al. Comprehensive renal scintillation procedures in spinal cord injury: comparison with excretory urography. J Urol. 1981;126:10-13.
2. Kuhlemeier KV, Huang CT, Lloyd LK, Fine PR, Stover SL. Effective renal plasma flow: clinical significance after spinal cord injury. J Urol. 1985;133:758-761.
3. Kuhlemeier KV, Huang CT, DeVivo MJ, Lloyd LK. Year-to-year changes in effective renal plasma flow in asymptomatic spinal cord injury patients. J Urol. 1986;28:270-274.
4. Russell CD, Thorstad B, Yester MV, Stutzman M, Dubovsky EV. Quantitation of renal function with Tc-99m-MAG3. J Nucl Med. 1988;29:1931-1933.
5. Russell CD, Dubovsky EV. Quantitation of renal function using MAG3 [editorial]. J Nucl Med. 1991;32:2061-2063.
6. Russell CD, Li Y, Kahraman HN, Dubovsky EV. Renal clearance of technetium-99m-MAG3: normal values [letter]. J Nucl Med. 1995;36:706-708.
7. Waites KB, Canupp KC, DeVivo MJ, Lloyd LK, Dubovsky EV. Compliance with annual urologic evaluations and preservation of renal function in persons with spinal cord injury. J Spinal Cord Med. 1995;18:251-254.
8. Russell CD, Taylor AT Jr, Dubovsky EV. Measurement of renal function with Tc-99m MAG3 in children and adults. J Nucl Med. 1996;37:588-593.
9. Piepsz A, Tondeur M, Kinthaert J, Ham HR. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance. Eur J Nucl Med. 1996;3:195-198.
10. m-MAG3 clearance under clinical conditions. Nucl Med Commun. 1997;18:352-357.
11. m-MAG3: a comparison with I125-OIH and Cr51-EDTA in patients representing all levels of glomerular filtration rate. Eur J Nucl Med. 1995;22:1379-1384.
12. Russell CD, Thorstad B, Yester MV, Stutzman M, Dubovsky EV. Quantitation of renal function with Tc-99m-MAG3. J Nucl Med. 1988;29:1931-1933.
13. Werner E. Reproducibility of technetium-99m-MAG3 clearance calculated by the Bubeck method. J Nucl Med. 1998;39:1066-1069.